WebStockholders can obtain these documents when they are filed and become available free of charge from the SEC’s website at www.sec.gov, or from Cubist upon written request to …
Did you know?
WebJun 11, 2012 · Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products that address significant unmet medical needs in the acute care environment. Cubist is headquartered in Lexington, Mass. Additional information can be found at Cubist's web site at … WebHe was previously Senior Vice President and Chief Financial Officer of Optimer Pharmaceuticals, Inc., a publicly traded biotechnology company, from July 2012 until its acquisition by Cubist Pharmaceuticals, Inc. in October 2013. Prior to joining Optimer, Mr. Webster served as SVP and Chief Financial Officer of Adolor Corporation, a ...
WebOct 24, 2011 · Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products that … WebCubist Pharmaceuticals Inc. said last week that it had reached an agreement with Pfizer Inc. to develop and sell antibacterial drugs. The terms were not disclosed.
WebMar 23, 2024 · CUBIST PHARMACEUTICALS INC (NASDAQ:) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share CUBIST PHARMACEUTICALS INC Nasdaq: Nasdaq WebBefore that, he was Chief Financial Officer at Cubist Pharmaceuticals, Inc., or Cubist, a Nasdaq-listed biopharmaceutical company. He was at Cubist from August 2010 to January 2015, through the company’s sale to Merck, and held a series of roles of increasing responsibility leading finance, investor relations and strategic sourcing.
WebJul 14, 2024 · Cubist Pharmaceuticals' mailing address is 65 Hayden Ave, LEXINGTON, MA 02421-7994, United States. The official website for the company is www.cubist.com. …
WebJul 30, 2013 · Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products that address significant unmet medical needs in ... boarding schools in johannesburg south africaWebMerck’s Rose-Colored Glasses in Cubist Deal. Just hours after announcing its $8.4 billion acquisition of Cubist Pharmaceuticals, a Delaware judge invalidated patents owned by the antibiotics maker. cliff livingston cardWebJun 11, 2012 · Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products that … boarding schools in l.aWebStockholders can obtain these documents when they are filed and become available free of charge from the SEC’s website at www.sec.gov, or from Cubist upon written request to the Investor Relations Department, Cubist Pharmaceuticals, Inc., 65 Hayden Avenue, Lexington, MA 02421, telephone number (781) 860-8533 or from Cubist’s website ... cliff little townWeb$ACXP In December 2014, Merck ( $MRK) paid US$9.5 billion for Cubist ( $CBST) largely to obtain marketing access to agents daptomycin and fidaxomicin. Acurx finds itself in an … boarding schools in kzn for girlsWebMerck hasn’t exactly made a fortune on its $9.5 billion Cubist Pharmaceuticals buyout, but now, a next-generation ant Shortly after Merck bought Cubist, it lost a patent fight over the ... boarding schools in magaliesWebA NOVEL TARGET-BASED DRUG DEVELOPMENT PROGRAM. Amount: $119,941.00. Not Available The development of efficient algorithms to process laser radar returns is required by the dramatic increases in capabilities of laser radar hardware. Freestyle Technologies, Inc. will d ... SBIR Phase I 1999 Department of Health and Human Services. cliff littlefield attorney tx